-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Lung Cancer Screening
-
Lung Cancer is Treatable When Found Early. So Why Don’t We Screen Everyone?
Advocate and survivor Jan Pezarro details how investing in a universal age-based lung cancer screening model can save both lives and health care costs.
-
A Comprehensive Framework: Integrating Smoking Cessation into LCS
Experts outline how Poland aims to reduce lung cancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.
-
New Data Strengthen the Link Between Air Pollution Exposure and Increased Lung Cancer Risk
Researchers addressed the role of PM2.5 in lung cancer initiation and screening outcomes, as well as how genetic and air pollution scores can identify those at an increased risk.
-
Balancing the Benefits and Harms of Lung Cancer Screening
In the National Lung Screening Trial, screening with 2 years of annual low-dose computed tomography (LDCT) achieved a 20% decrease in lung cancer mortality in high-risk populations when compared with chest radiography. A decade later, in March 2021, the U.S. Preventive Services Task Force (USPSTF) expanded the eligibility for U.S. adults to ages 50 to…
-
Advancing Combined Modality Therapy for Early-Stage, Screen-Detected Disease: Adjuvant/Neoadjuvant Therapy
During the 17th annual Quantitative Imaging Workshop held in late Fall 2020, the Initiative for Early Lung Cancer Research on Treatment (IELCART) offered two sessions with panel discussions exploring the curative potential and challenges of managing early-stage, screen-detected lung cancer. IELCART investigators with well-established screening programs are recognizing a shift in the proportion of early-stage…
-
Differences in Smoking and Lung Cancer Incidence Among Black and White Young Adults in the United States
In the United States, racial disparities in lung cancer incidence are known to exist. This is most likely caused by higher smoking prevalence among non-Hispanic Black adults compared to non-Hispanic White adults.1 In addition, a higher tobacco-associated lung cancer risk for Black adults has been observed.2 Recently, Jemal et al. described their findings of changes…
-
Lung Cancer Screening in Poland Pilot Program Is Restarted After COVID-19 Lockdown
Discussions about lung cancer screening in Poland started in 2006, and between 2008 and 2010 four lung cancer screening programs were independently implemented by thoracic surgeons in Szczecin, Gdańsk, Poznań, and Warsaw, each with separate funding. From that point until 2018, more than 50,000 individuals at high risk of developing lung cancer were examined through…
-
Should We Delay Lung Cancer Screening During the COVID-19 Pandemic?
To address the issue of low-dose CT screening, during the COVID-19 pandemic, for lung cancer and management of both screen-detected nodules and incidentally detected nodules, various eminent organizations and expert groups have created guidance documents.1-4 The overarching principal guiding safe resumption of nonurgent imaging is clearly stated in a separate document by the American College…
-
Experts Discuss Benefits, Challenges with Lung Cancer Screening: A Pro/Con
Using LDCT to Boost Lung Cancer Prevention Strategies: A Pro/Con By Ugo Pastorino, MD Now we know from robust randomized trials that systematic screening with low-dose computed tomography (LDCT) of the chest can reduce lung cancer mortality in heavy smokers by increasing the proportion of cases detected in an early stage,1,2 when they are amenable…
-
On the Backs of Specialists: LDCT Screening Has Heightened the Importance of Recent Improvements in Surgical and Radiation Techniques
By Brendon Stiles, MD, and Drew Moghanaki, MD, MPH Posted: June 24, 2020 Annual low-dose computed tomography (LDCT) detects more early-stage lung cancers and saves lives by preventing death in people who develop lung cancer. The recent report on the long-term follow-up of patients in the National Lung Screening Trial (NLST) makes a powerful argument…